Hybridized quantum dot, silica, and gold nanoparticles for targeted chemo-radiotherapy in colorectal cancer theranostics

Amir Abrishami,Ahmad Reza Bahrami,Sirous Nekooei,Amir Sh. Saljooghi,Maryam M. Matin

DOI: https://doi.org/10.1038/s42003-024-06043-6

IF: 6.548

2024-04-02

Communications Biology

Abstract:Multimodal nanoparticles, utilizing quantum dots (QDs), mesoporous silica nanoparticles (MSNs), and gold nanoparticles (Au NPs), offer substantial potential as a smart and targeted drug delivery system for simultaneous cancer therapy and imaging. This method entails coating magnetic GZCIS/ZnS QDs with mesoporous silica, loading epirubicin into the pores, capping with Au NPs, PEGylation, and conjugating with epithelial cell adhesion molecule (EpCAM) aptamers to actively target colorectal cancer (CRC) cells. This study showcases the hybrid QD@MSN-EPI-Au-PEG-Apt nanocarriers (size ~65 nm) with comprehensive characterizations post-synthesis. In vitro studies demonstrate the selective cytotoxicity of these targeted nanocarriers towards HT-29 cells compared to CHO cells, leading to a significant reduction in HT-29 cell survival when combined with irradiation. Targeted delivery of nanocarriers in vivo is validated by enhanced anti-tumor effects with reduced side effects following chemo-radiotherapy, along with imaging in a CRC mouse model. This approach holds promise for improved CRC theranostics.

biology

What problem does this paper attempt to address?

This paper aims to address the challenges in the treatment of colorectal cancer (CRC), especially the problem that traditional treatment methods often fail in the face of CRC drug resistance and recurrence. The author proposes an innovative solution, namely, using a hybrid nanocarrier system of quantum dots (QDs), mesoporous silica nanoparticles (MSNs) and gold nanoparticles (Au NPs) to achieve targeted chemo - radiotherapy combination therapy for colorectal cancer cells.

Specifically, this study attempts to solve the problem in the following ways:

1. **Improve the targeting of drug delivery**: By combining quantum dots, mesoporous silica nanoparticles and gold nanoparticles and further modifying the epithelial cell adhesion molecule (EpCAM) aptamer, selective targeting of colorectal cancer cells is achieved. This helps to reduce the side effects of drugs on normal tissues.

2. **Enhance the treatment effect**: Combining chemotherapy drugs (such as epirubicin EPI) and radiotherapy sensitizers (such as Au NPs), and triggering drug release through the acidic tumor micro - environment, thereby improving the treatment effect. In addition, the radiosensitization effect of Au NPs can enhance the lethality of X - rays to tumor cells.

3. **Multimodal imaging**: Through multiple imaging techniques such as fluorescence imaging (FLI), magnetic resonance imaging (MRI) and computed tomography (CT), the in - vivo distribution of nanocarriers is monitored in real - time to ensure that drugs are accurately delivered to the tumor site.

4. **Overcome the limitations of existing therapies**: Traditional chemotherapy and radiotherapy are often accompanied by serious side effects, and this new nanocarrier system can improve the curative effect while reducing side effects, providing a more effective and safer method for the treatment of colorectal cancer.

In summary, this paper attempts to improve the diagnosis and treatment of colorectal cancer by developing a multifunctional nanocarrier system, and has made significant progress especially in improving targeting and reducing side effects.